Galderma Receives U.S. FDA Approval For Restylane® Lyft™ For The Enhancement Of The Chin Profile

Reuters
Nov 20
Nov 5 (Reuters) - GALDERMA GROUP AG ::
*RECEIVES U.S. FDA APPROVAL FOR RESTYLANE® LYFT™ FOR THE ENHANCEMENT OF THE CHIN PROFILE

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 05-NOV-202506:00:00.227 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10